AvandiaŽ SmithKline Beecham Pharmaceuticals
David E. Wheadon, MD VP & Director, North American Regulatory Affairs
Introduction and Preclinical Highlights
Anthony S. Rebuck, MD VP & Director, Pulmonary and Diabetes Therapeutic Unit
Elizabeth B. Rappaport, MD Group Director, Diabetes and Metabolism
Douglas A. Greene, MD Professor, Internal Medicine; Director, Michigan Diabetes Research Center University of Michigan
Tadataka Yamada, MD Chairman, Research & Development, SmithKline Beecham Pharmaceuticals